Natixis Advisors LLC Purchases 10,706 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Natixis Advisors LLC raised its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 10.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 116,809 shares of the medical device company's stock after acquiring an additional 10,706 shares during the period. Natixis Advisors LLC owned approximately 0.06% of Cooper Companies worth $10,738,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Cooper Companies in the 4th quarter valued at $691,000. Highland Capital Management LLC acquired a new position in shares of Cooper Companies in the 4th quarter valued at $4,004,000. Caprock Group LLC acquired a new position in shares of Cooper Companies in the 4th quarter valued at $282,000. Franklin Resources Inc. grew its holdings in shares of Cooper Companies by 194.0% in the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company's stock valued at $5,265,000 after buying an additional 32,260 shares during the period. Finally, Principal Financial Group Inc. grew its holdings in shares of Cooper Companies by 6.6% in the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company's stock valued at $26,295,000 after buying an additional 14,687 shares during the period. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Up 1.6 %

Shares of Cooper Companies stock traded up $1.32 during trading hours on Friday, reaching $81.71. 3,706,219 shares of the company's stock were exchanged, compared to its average volume of 1,283,371. The company has a 50 day moving average of $90.05 and a two-hundred day moving average of $98.09. The Cooper Companies, Inc. has a fifty-two week low of $77.05 and a fifty-two week high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market cap of $16.34 billion, a P/E ratio of 41.90, a P/E/G ratio of 2.25 and a beta of 1.02.

Remove Ads

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on COO shares. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 11th. JPMorgan Chase & Co. reduced their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of "Moderate Buy" and an average price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.